Global Enteral Formula Market to Reach USD 15.6 Billion by 2034, Expanding at a 6.9% CAGR | Future Market Insights, Inc.

The global Enteral Formula industry has an estimated market valuation of USD 8.0 billion by 2024 and is projected to grow at a CAGR of 6.9 % to reach a market valuation of USD 15.6 billion by 2034.

The market for enteral formulas appears to be full of opportunities for product differentiation and further development which shows high growth rates. Manufacturers can diversify existing product categories by adding new subcategories which include; Low allergen, high-protein, and plant-based. New products developed from enhanced formulations such as those that work well for metabolic disorders and malabsorption diseases will generate more patient and even more medical practitioners’ interests. Moreover, the distribution networks will also be upgraded specifically in the context of e-shops, which will help consumers in terms of making necessary nutrition products easily available to them. Healthcare organizations and registered dietitians should also be engaged to improve brand authenticity and increase awareness of enteral nutrition in the delivery of patient care.

Another important segment where enteral formula manufacturers can access growth is environmental sustainability. Being a social responsibility, the awareness of sustainable consumption enables the implementation of sustainable measures from the acquisition of raw materials, packaging, and the making of the foods. Integration of environmentally friendly materials in products and cutting on wastage will be persuasive to consumers in the market due to much competition. Coping with these chances for diversification and sustainability, companies will not only address the shifting needs of patients but also create a more inventive and proper healthcare industry that will produce impressive market growth in the future years.

Request Sample Copy: https://www.futuremarketinsights.com/report-sample#5245502d47422d3139383732

Key Takeaways from the Global Enteral Formula Market Study:

  • Sustainability initiatives have become an important value proposition for manufacturers and are widely integrated into strategic business objectives. While maintaining compliance with established legal rules and regulations concerning the environmental management of their purchases, packaging, and production, they also create more brand awareness and value by addressing the needs of sustainable consumers.
  • It is a good fact in the manufacturing industry that innovation is a critical success factor when designing products. Instead, looking at higher protein, allergen-free, and plant-based options as well as other niche formulas, companies are not only meeting consumer trends but also building a competitive advantage in their product portfolios.

“Companies that obtain certifications and accreditation, as well as form innovation hubs and centers for more R&D in Enteral Formula, will have higher consumer trust and reliability and graduate to the top tier of the market leadership” – says Nandini Roy Choudhury, Client Partner at Future Market Insights 

Country-wise Insights

Countries CAGR 2024 to 2034
The USA 7.2%
South Korea 7.7%
Japan 7.5%
China 7.0%

Who is winning?

The enteral formula market competition is considered to be highly driven by key stakeholders including Abbott Laboratories, Nestlé Health Science, and Danone. These companies are winning through product diversification, new formulations, and mergers and acquisitions including Danone’s acquisition of Functional Formularies. Meant for Chronic ailments and increasing elderly customers paired with strong growth in points of sale especially the e-commerce front end greatly against new entrants that they can easily thwart to retain huge market share and robust growth rates.

  • In 2024, Danone increased its medical nutrition through the acquisition of Functional Formularies, a whole foods tube-feeding company in the United States of America. This strategic move will be to the effect of diversifying Danone’s product line that caters to patients with certain health complications; especially the enteral tube feeding markets. Juergen Esser – the deputy CEO of Danone said that they are delighted regarding the acquisition of the firm because the product complements some of the foods they have in the Real Food Blends range that is used to feed tube-fed patients. This move was in line with its strategic direction because it needs to expand its specialty nutrition due to changing consumer trends.

Leading Brands

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International
  • Danone (Nutricia)
  • EN Otsuka Pharmaceutical Co., Ltd.
  • Fresenius Kabi AG
  • Herbalife Nutrition Ltd.
  • Mead Johnson Nutrition (Reckitt Benckiser)
  • Medtrition, Inc.
  • Meiji Holdings Co., Ltd.
  • Nestle SA
  • Pediatric Nutrition Company (PediaSure)
  • Victus, Inc.
  • Vonco Products, LLC.
  • WHOLE Enteral Nourishment
  • Others

Detailed Market Study: Full Report and Analysis https://www.futuremarketinsights.com/reports/enteral-formula-market

Get valuable insights into the Global Enteral Formula Market:

Future Market Insights, in its new offering, provides a thorough, detailed, and unbiased analysis of the Global Enteral Formula Market, presenting Historical Demand data for the years 2019-2023 and Forecast statistics for the years 2024-2034.

The study categorizes valuable insights on the Global Enteral Formula Industry based on Product Type, Health Claim, Product Format, Sales Channel, Administration Methods, Feeding Type, and Region. As per product type, the industry has been categorized into Standard Formulas, Elemental Formulas, Blenderized Formulas (with Real Food Ingredients), Specialized Formulas, High-Protein Formulas, Fiber-Enriched Formulas, Caloric-Dense Formulas, and Peptide Formulas (Semi-Elemental Formulas). As per health claims, the industry has been categorized into Adults [Chronic Obstructive Pulmonary Disease (COPD), Cancer, Stroke, Diabetes, Malnutrition, Gastroparesis, Renal Failure, Multiple Sclerosis (MS), Traumatic Brain Injury (TBI), and Heart Failure], Kids [Failure to Thrive, Food Allergies or Intolerances, Cystic Fibrosis, Neurological Disorders, Gastroesophageal Reflux Disease (GERD), Short Bowel Syndrome, Anorexia or Eating Disorders, Inborn Errors of Metabolism, Pediatric Cancer, and Severe Infections], and Geriatric [Dysphagia, Malnutrition, Parkinson’s Disease, Alzheimer’s Disease/Dementia, Post-Surgical Recovery, Chronic Kidney Disease, Heart Failure, Cancer, Chronic Pain Conditions, and Diabetes]. The product format segment is further categorized into Liquid Formulas, Powder Formulas, Semi-Solid Formulas, and Ready-to-Use Formulas. As per sales channel, the industry has been categorized into Prescription (Dietician/Nutritionists, and Hospitals (Private & Public) & Clinics), Over-the-Counter (Modern Trade, Hospital Pharmacies, Retail Pharmacies, and Drug Stores), and Online Pharmacies. The administration method segment is further categorized into Tube Feeding (Nasogastric Tube, Gastrostomy Tube, Jejunostomy Tube, and Percutaneous Endoscopic Gastrostomy), and Oral Administration. The feeding type segment is further categorized into Continuous, Intermittent, and Bolus. Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these